-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

Pfizer Says 20-Valent Pneumococcal Conjugate Vaccine Candidate Application Accepted for US FDA Priority Review

Pfizer Says 20-Valent Pneumococcal Conjugate Vaccine Candidate Application Accepted for US FDA Priority Review

MT Newswires · 01/06/2023 02:42